Early Postseroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1–Postive Subjects Receiving Antiretroviral Therapy
Hemant Kulkarni(The University of Texas at San Antonio Health Science Center), Vincent C. Marconi(Emory University), Nancy F. Crum‐Cianflone(Henry M. Jackson Foundation), Michael A. Polis(National Institutes of Health), Braden Hale(Naval Medical Center San Diego), Glenn Wortmann(Walter Reed National Military Medical Center), Matthew J. Dolan(The University of Melbourne), Edmund C. Tramont(National Institute of Allergy and Infectious Diseases), Jason F. Okulicz(Gilead Sciences (United States)), Michael L. Landrum(San Antonio Military Medical Center), Alan R. Lifson(University of Minnesota), Brian K. Agan(Henry M. Jackson Foundation), G Grandits(Rush University Medical Center), Sunil K. Ahuja(South Texas Veterans Health Care System)
Cited by 27
Related Papers
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
The Belle II Physics Book
|Progress of Theoretical and Experimental Physics|2020|286
A taste of dark matter: flavour constraints on pseudoscalar mediators
|Journal of High Energy Physics|2015|231